Tirosint
- Product NDC
- 71858-0017
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- levothyroxine sodium
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- IBSA Pharma Inc.
- Application
- NDA021924
- Marketing category
- NDA
- Substance
- LEVOTHYROXINE SODIUM
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 71858-0017-1 | 1 BLISTER PACK in 1 CARTON (71858-0017-1) / 10 CAPSULE in 1 BLISTER PACK | 2023-03-01 | 2026-07-22 | Yes | Historical |
| 71858-0017-2 | 3 BLISTER PACK in 1 CARTON (71858-0017-2) / 10 CAPSULE in 1 BLISTER PACK | 2025-08-24 | | Yes | Historical |
| 71858-0017-4 | 3 BLISTER PACK in 1 CARTON (71858-0017-4) / 10 CAPSULE in 1 BLISTER PACK | 2023-03-01 | | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Tirosint | IBSA Pharma Inc. | 2026-03-25 | HUMAN PRESCRIPTION DRUG LABEL | 13 |